Company · CIK 0001849296 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
OKYO Pharma Ltd · OKYO
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2026 PForm 4/A → | Aug 7, 4:15 pm EDT | Rajkumar V. PatilChief Scientific Officer | 3,363 | $1.49 | $5,011 | 20,030 | +20.2% | |
| Jul 27, 2026 AForm 4 → | Jul 29, 4:45 pm EDT | Rajkumar V. PatilChief Scientific Officer | 3,363 | $1.49 | $5,011 | 20,030 | — | amended |
| Jul 22, 2026 PForm 4/A → | Aug 7, 4:15 pm EDT | Robert John DempseyCHIEF EXECUTIVE OFFICER, Director | 15,000 | $1.54 | $23,085 | 15,000 | — | |
| Jul 22, 2026 AForm 4 → | Jul 23, 4:20 pm EDT | Robert John DempseyCHIEF EXECUTIVE OFFICER, Director | 15,000 | $1.54 | $23,085 | 15,000 | — | amended |
| Jul 21, 2026 PForm 4/A → | Aug 7, 4:15 pm EDT | John P BrancaccioDirector | 5,000 | $1.48 | $7,385 | 35,201 | +16.6% | |
| Jul 21, 2026 PForm 4/A → | Aug 7, 4:15 pm EDT | Gary S JacobCHIEF DEVELOPMENT OFFICER, Director | 3,500 | $1.40 | $4,900 | 112,420 | +3.21% | |
| Jul 21, 2026 PForm 4/A → | Aug 7, 4:15 pm EDT | Gabriele M CerroneDirector, 10% Owner | 22,500 | $1.45 | $32,625 | 10,873,916 | +0.21% | |
| Jul 21, 2026 PForm 4/A → | Aug 7, 4:15 pm EDT | Flavio MantelliCHIEF MEDICAL OFFICER | 20,000 | $1.40 | $28,000 | 20,000 | — | |
| Jul 21, 2026 AForm 4 → | Jul 23, 4:15 pm EDT | Gabriele M CerroneDirector, 10% Owner | 22,500 | $1.45 | $32,625 | 10,873,916 | — | amended |
| Jul 21, 2026 AForm 4 → | Jul 23, 4:15 pm EDT | Gary S JacobCHIEF DEVELOPMENT OFFICER, Director | 3,500 | $1.40 | $4,900 | 112,420 | — | amended |
| Jul 21, 2026 AForm 4 → | Jul 23, 4:15 pm EDT | John P BrancaccioDirector | 5,000 | $1.48 | $7,385 | 35,201 | — | amended |
| Jul 21, 2026 AForm 4 → | Jul 22, 4:15 pm EDT | Flavio MantelliCHIEF MEDICAL OFFICER | 20,000 | $1.40 | $28,000 | 20,000 | — | amended |
| Jul 20, 2026 PForm 4/A → | Aug 7, 4:15 pm EDT | Gabriele M CerroneDirector, 10% Owner | 25,000 | $1.40 | $35,000 | 10,851,416 | +0.23% | |
| Jul 20, 2026 AForm 4 → | Jul 21, 4:15 pm EDT | Gabriele M CerroneDirector, 10% Owner | 25,000 | $1.40 | $35,000 | 10,851,416 | — | amended |
| Jun 8, 2026 AForm 4 → | Jun 10, 4:30 pm EDT | Gabriele M CerroneDirector, 10% Owner | 300,000 | $1.72 | $516,000 | 10,826,416 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 8, 2026 AForm 4 → | Jun 10, 5:00 pm EDT | Bernard DenoyerDirector | 3,500 | $1.85 | $6,475 | 35,190 | — | |
| Jun 8, 2026 AForm 4 → | Jun 10, 5:00 pm EDT | John P BrancaccioDirector | 6,500 | $1.85 | $12,025 | 138,394 | — | |
| Jun 8, 2026 AForm 4 → | Jun 10, 5:00 pm EDT | Willy Jules SimonDirector | 6,500 | $1.85 | $12,025 | 135,502 | — | |
| Jun 8, 2026 AForm 4 → | Jun 10, 5:00 pm EDT | Keeren Rameshchandra ShahChief Financial Officer | 40,000 | $1.85 | $74,000 | 544,819 | — |